CLINICAL_TRIALS
trial_result
· 2016-04-07
Clinical Trial Update: A Study of Nilotinib Versus Imatinib in GIST Patients [Phase 3]
Summary
Phase 3 trial comparing nilotinib to imatinib in gastrointestinal stromal tumor has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Gastrointestinal Stromal Tumor (GIST) | Phase 3 | Status: COMPLETED | Results posted: 2016-04-07